{"id":"W4417498650","doi":"10.1080/21678421.2025.2597935","title":"Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial","year":2025,"lang":"en","type":"article","venue":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Mitsubishi Tanabe Pharma Corporation; Denali Therapeutics; Cytokinetics; Biogen; ALS Association; Muscular Dystrophy Association; Acorda Therapeutics; Arthur M. Blank Family Foundation; UCB Pharma; Alexion Pharmaceuticals","keywords":"Subgroup analysis; Amyotrophic lateral sclerosis; Placebo; Exploratory analysis; Regimen; Clinical endpoint; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001984155,0.0002059019,0.0002543904,0.00003160731,0.0001582348,0.00008906048,0.0001064778,0.0001682229,0.00004112957],"category_scores_gemma":[0.00002627467,0.0001249553,0.00009954365,0.00009528969,0.00004250326,0.00001840411,0.00006214961,0.00007182058,0.000002711218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006100526,"about_ca_system_score_gemma":0.0000438745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002367353,"about_ca_topic_score_gemma":0.001566747,"domain_scores_codex":[0.9988211,0.000150164,0.0003112378,0.0003885948,0.0001013906,0.0002275107],"domain_scores_gemma":[0.9996113,0.00003254838,0.00007854247,0.0001834607,0.00002658792,0.00006758274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003033977,0.00013891,0.003635296,0.00000382134,0.00008327707,0.000001673443,0.00004284096,0.000160962,0.981575,0.0001959719,0.001224809,0.009903467],"study_design_scores_gemma":[0.04065056,0.003585519,0.1468739,0.0001099942,0.0001967077,0.00000134034,0.00004764172,0.004698046,0.7911137,0.002277041,0.009793438,0.0006521786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947493,0.002682219,0.0005782922,0.0008651056,0.000403926,0.0006026794,0.00003194706,0.00001217902,0.00007432803],"genre_scores_gemma":[0.9956471,0.001997703,0.0003016214,0.0008231168,0.0004757259,0.0001441886,0.0003850259,0.000009112305,0.0002163639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1904614,"threshold_uncertainty_score":0.5095528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07429008041863687,"score_gpt":0.3323737811230257,"score_spread":0.2580837007043888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}